Mary Jo M. Dales

News

Smoldering myeloma progressed more rapidly in patients with elevated BMIs

Author:: Mary Jo M. Dales

Publish date: May 19, 2017

An elevated body mass index appears to be a risk factor for progression of smoldering multiple myeloma, according to Wilson I. Gonsalves, MD, and h...

News

Myeloma patients who get solid tumor cancers do as well as other cancer patients

Author:: Mary Jo M. Dales

Publish date: May 19, 2017

With improved treatment, patients with multiple myeloma are surviving long enough to develop other cancers, Jorge J. Castillo, MD, and Adam J. Olsz...

News

Lenalidomide maintenance boosted depth of response in myeloma patients

Author:: Mary Jo M. Dales

Publish date: May 19, 2017

Lenalidomide maintenance therapy further improved depth of response in newly diagnosed, transplant-eligible patients with multiple myeloma in the E...

News

Daratumumab, elotuzumab eyed for initial treatment of myeloma

Author:: Mary Jo M. Dales

Publish date: May 4, 2017

The emerging role for immunotherapies as an essential component of multiple myeloma therapy is examined in a review article in Leukemia by Cyrille ...

News

Guideline endorses doublet therapy after pancreatic cancer surgery in chemo-naive patients

Author:: Mary Jo M. Dales

Publish date: April 17, 2017

ASCO has updated a pancreatic cancer guideline based on results of the ESPAC-4 study.

News

CLL boost in PFS came at high cost in side effects

Author:: Mary Jo M. Dales

Publish date: March 8, 2017

Add-on idelalisib boosted the progression-free survival of patients with relapsed and refractory chronic lymphocytic leukemia, but at a price.

News

Thrombotic microangiopathy may signal IV drug abuse

Author:: Mary Jo M. Dales

Publish date: February 23, 2017

Thrombotic microangiopathy may be triggered by IV drug abuse of extended-release oxymorphone hydrochloride tablets.

Video

VIDEO: First multicenter trial of CAR T cells shows response in DLBCL

Author:: Mary Jo M. Dales

Publish date: January 19, 2017

SAN DIEGO - Aggressive, refractory non-Hodgkin lymphomas responded to anti-CD19 chimeric antigen receptor T cells in ZUMA-1, the first multic...

Article

VIDEO: SPIN tests hydroxyurea to prevent pediatric stroke in sickle cell disease

Author:: Mary Jo M. Dales

Publish date: December 5, 2016

SAN DIEGO - Whether hydroxyurea can avert a first stroke in children with sickle cell disease is a question that may be answered by a soon-to...

Article

VIDEO: Venetoclax shows early good results in multiple myeloma

Author:: Mary Jo M. Dales

Publish date: December 4, 2016

SAN DIEGO – Venetoclax has shown preliminary good results as an investigational monotherapy in patients with relapsed/refractory multiple myeloma, ...